Case Report

Contrasting Outcomes in Two High-Risk Pregnancies: A Clinical Experience in Diagnostic Delay vs. Multidisciplinary Success

Abstract

Pregnancy significantly alters the clinical presentation of various diseases, often masking or mimicking symptoms of serious underlying conditions. In high-risk pregnancies, overlooking nonspecific symptoms may delay the diagnosis of life-threatening disorders, resulting in poor maternal and fetal outcomes. This report describes two rare cases of pregnancy in women with complex medical histories. The first patient, a 34-year-old at 30 weeks’ gestation, was diagnosed with invasive ductal breast cancer with extensive bone and pulmonary metastases, as well as hypercalcemia-induced renal failure. Despite emergency dialysis, respiratory support, spinal anesthesia for delivery, and coordinated care from nephrology, endocrinology, obstetrics, and anesthesiology teams, her condition worsened postpartum. She developed respiratory acidosis and decreased consciousness, and required intubation. Although initially stabilized and her malignancy confirmed via
biopsy, she progressed to multi-organ failure and died from asystole 5 days postpartum, on January 22, 2025, despite resuscitation. The second patient, also 34, had a history of repaired congenital heart disease and right-sided invasive ductal carcinoma. Against medical advice, she pursued a high-risk spontaneous pregnancy, closely monitored by a multidisciplinary team. Her hypertension and gestational diabetes were managed with
medications and insulin, respectively. At 37 weeks, she underwent elective cesarean section at a tertiary center, delivering a healthy boy with normal weight and Apgar scores of 9 and 10. She was discharged hemodynamically stable from the ICU, approved for breastfeeding, and scheduled to start chemotherapy on March 10, 2025. These contrasting cases demonstrate how outcomes in high-risk pregnancies are profoundly influenced by timely diagnosis and coordinated care. Nonspecific symptoms during pregnancy should
prompt thorough evaluation, especially in the absence of antenatal care. A structured, team-based approach can significantly improve maternal and neonatal outcomes, even in medically complex scenarios.

[1] Guimarães T, Magalhães A, Veiga A, Fiuza M, Ávila W, Pinto FJ. Heart disease and pregnancy: State of the art. Rev Port Cardiol. 2019;38(5):373-83. https://doi.org/10.1016/j. repc.2018.05.013
[2] Parsonage WA, Zentner D, Lust K, Kane SC, Sullivan EA. Heart disease and pregnancy: the need for a twenty-first century approach to care. Heart Lung Circ. 2021;30(1):45-51. https://doi.org/10.1016/j.hlc.2020.06.021
[3] Meng ML, Arendt KW. Obstetric anesthesia and heart disease: practical clinical considerations. Anesthesiology.
2021;135(1):164-83. https://doi.org/10.1097/ALN.0000000000003833
[4] Goldstein SA, Ward CC. Congenital and acquired valvular heart disease in pregnancy. Curr Cardiol Rep. 2017;19(10):96. https://doi.org/10.1007/s11886-017-0910-6
[5] Gnanaraj JP, Princy SA, Sliwa-Hahnle K, et al. Tamil Nadu Pregnancy and Heart Disease Registry (TNPHDR): design and methodology. BMC Pregnancy Childbirth. 2022;22(1):80. https://doi.org/10.1186/s12884-021-04305-3
[6] Cossío-Aranda JE, Gaspar-Hernández J, Juanico-Enriquez A, et al. Pregnancy in teenagers with heart disease. Arch
Cardiol Mex. 2020;90(1):81-5. https://doi.org/10.24875/ACM.19000184
[7] Boere I, Lok C, Poortmans P, et al. Breast cancer during pregnancy: epidemiology, phenotypes, presentation during
pregnancy and therapeutic modalities. Best Pract Res Clin Obstet Gynaecol. 2022;82:46-59. https://doi.org/10.1016/j.
bpobgyn.2022.05.001
[8] Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol. 2016;59(4):651-72. https://doi.
org/10.1097/GRF.0000000000000239
[9] Bajpai J, Pathak R, Shylasree TS, Rugo HS. Management of breast cancer diagnosed during pregnancy: global
perspectives. Expert Rev Anticancer Ther. 2022;22(12):1301-8. https://doi.org/10.1080/14737140.2022.2150167
[10] Rossi L, Mazzara C, Pagani O. Diagnosis and treatment of breast cancer in young women. Curr Treat Options Oncol.
2019;20(12):86. https://doi.org/10.1007/s11864-019-0685-7
[11] Safi N, Saunders C, Anazodo A, et al. Clinical decision making in the management of breast cancer diagnosed during pregnancy: a review and case series analysis. J Adolesc Young Adult Oncol. 2022;11(3):245-51. https://doi.org/10.1089/jayao.2021.0054
Files
IssueVol 10 No 1 (2025): January-February QRcode
SectionCase Report(s)
Keywords
High-risk Pregnancy Congenital heart disease Breast cancer Chemotherapy Multidisciplinary management

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Ghasemi Tirtashi M, Ebadi Jamkhane A, Zamaniyan M, Nezhad Naderi N, Shabankhani K. Contrasting Outcomes in Two High-Risk Pregnancies: A Clinical Experience in Diagnostic Delay vs. Multidisciplinary Success. CRCP. 2025;10(1):43-47.